Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients-Reference-Cited by-同舟云学术

Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients

Published:2012-02 Issue:2 Volume:36 Page:182-185
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rigacci Luigi,Landi Carla,Caruso Jean Pierre,Puccini Benedetta,Alterini Renato,Carrai Valentina,Perrone Tania,Bosi Alberto

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Chemotherapy-induced nausea vomiting;Hesketh;N Engl J Med,2008

2. Guidelines update for MASCC and ESMO in the prevention of chemohterapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference;Roila;Ann Oncol,2010

3. Antiemesis (2011) NCCN clinical practice guidelines in oncology. V.3., http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf; 2011 [accessed 04.05.11].

4. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP;Bonadonna;Cancer,1975

5. Proposal for classifying the acute emetogenicity of cancer chemotherapy;Hesketh;J Clin Oncol,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of induced nausea and vomiting in patients with malignant blood disorders. Experience of using netupitant/palonosetron (Akynzeo);MD-Onco;2022-12-14

2. The effectiveness of a provincial symptom assessment program in reaching adolescents and young adults with cancer: A population‐based cohort study;Cancer Medicine;2021-11-05

3. Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin’s lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience;International Journal of Hematologic Oncology;2020-03-01

4. Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center;Acta Haematologica;2018

5. Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen;Supportive Care in Cancer;2017-08-02